Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Cataract News Editors

News Widget

Display the Cataract news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Cataract News

News on Cataract continually updated from thousands of sources around the net.

Friday | Beckers ASC Review

8 Recent Eye Surgery Center Openings, Mergers & Acquisitions

Hoopes Vision has opened an eye surgery facility in Draper, Utah. The facility includes the ambulatory surgery center EyeSurg of Utah , examination rooms, a laser surgery suite and clinical research center.

Comment?

Related Topix: Draper, UT, Corrective Eye Surgery, Health, Macular Degeneration, Medicine

Sat May 18, 2013

BruDirect

Mobile Eye Clinic Visits Kampong Kapok Kanan

A cataract is a common cause of eye problems among Bruneians, said Dyg Nurbazilah Awang Bazlan, an Eye Clinic Officer from R1PAS Hospital.

Comment?

Related Topix: Medicine, Health

Tue Apr 30, 2013

BioSpace

Omeros Corporation Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review

OMS302, which contains mydriatic and anti-inflammatory agents, is the Company's product being developed for use during intraocular lens replacement, including cataract surgery and refractive lens exchange.

Comment?

Related Topix: Biotech, Omeros, Medicine, Ophthalmology, Marketing, Health, Food and Drug Administration

Thu Apr 25, 2013

Applied Clinical Trials

Omeros Reports OMS302 Clinical Data Presented at the Annual ASCRS and ASOA Symposium and Congress

Data Show that OMS302 Maintains Pupil Size During Lens Replacement Surgery by Not Only Promoting Mydriasis but also by Preventing Miosis -- -- Data Show that OMS302 Maintains Pupil Size During Lens Replacement Surgery by Not Only Promoting Mydriasis but also by Preventing Miosis -- /PRNewswire/ -- Omeros Corporation today reported analyses of Phase ... (more)

Comment?

Related Topix: Biotech, Omeros, Medicine, Health, Marketing

Fri Apr 19, 2013

Sys-Con Media

Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress

The podium presentation, "Effect of an Anti-inflammatory-Mydriatic Agent on the Incidence of Intraoperative Miosis During IOL Replacement Surgery," summarizes key analyses of Phase 2 and Phase 3 clinical data assessing the ability of OMS302 to reduce the incidence of miosis during intraoperative lens replacement surgery.

Comment?

Related Topix: Biotech, Omeros, Medicine, Health, Marketing, Acular, Ketorolac (generic), Toradol, Ketorolac (generic), Food and Drug Administration